Junevity's Bold Move: Using siRNA to Fight Diabetes and Obesity

News
Video

In this quick clip from our BIO 2025 interview with Junevity Co-founder and CEO John Hoekman, PhD, Dr. Hoekman summarizes the potential of siRNA to fight diseases like diabetes and obesity.

Check out the full interview here!

Newsletter

Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.

Recent Videos
DC skyline at night with view of the White House and the Washington Monument | Image Credit: © Jessica - stock.adobe.com
Daniel Fischer, Tevard
Related Content
© 2025 MJH Life Sciences

All rights reserved.